Article Text

Download PDFPDF
Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis
  1. P SCHNEIDER,
  2. V GREENE,
  3. J KANOLD,
  4. J-P VANNIER
  1. Hopital Charles Nicolle, 1 rue de Germont
  2. 76000 Rouen, France
  1. Prof JP Vannier (Jean-Pierre.vannier{at}chu-rouen.fr)

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Editor,—Familial haemophagocytic lymphohistiocytosis (FHL) is a lethal disease with an uncontrolled activation of T lymphocytes and macrophages due to a perforin gene defect.1 The only current curative treatment is bone marrow transplantation. However, favourable outcome is associated with clinical remission status at the time of the procedure.2 ,3 Unfortunately, the use of steroids, etoposide (VP16), cyclosporin A, and antithymocyte globulins alone or in association frequently fails to control recurrent active phases.

BL, a 2 month old boy, was admitted in June …

View Full Text

Linked Articles

  • Rapid responses
    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
  • Rapid responses
    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health